BIOSIMILAR

Novartis wins European approval for biosimilar version of Roche`s MabThera

Novartis wins European approval for biosimilar version of Roche`s MabThera

Published 19/06/2017

Swiss drugmaker Novartis on Monday said it had won European approval for its biosimilar version of Roche's blockbuster Rituxan as the crosstown rivals go head-to-head on a drug to treat blood cancers and immunological diseases.

[more…]

FDA approves Amgen`s copy of AbbVie arthritis drug Humira

FDA approves Amgen`s copy of AbbVie arthritis drug Humira

Published 27/09/2016

The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar version of AbbVie's top-selling arthritis drug, Humira.

[more…]

Samsung brings in the lawyers for biosimilars push

Samsung brings in the lawyers for biosimilars push

Published 03/04/2016

SEOUL Samsung Bioepis Co Ltd, which aims to become a force in the fledgling biosimilar drugs industry, has filed a lawsuit against the originator of [more…]